- New York Abilify Lawsuit Lawyer
- New York Actos Lawsuit Lawyer
- New York Benicar Lawsuit Lawyer
- New York Invokana Lawsuit Lawyer
- New York Januvia Lawsuit Lawyer
- New York Onglyza and Kombiglyze XR Lawsuit Lawyer
- New York Opioids Lawsuit Lawyer
- New York Pradaxa Lawsuit Lawyer
- New York Risperdal Lawsuit Lawyer
- New York Talcum Powder Lawsuit Lawyer
- New York Taxotere Lawsuit Lawyer
- New York Victoza Lawsuit Lawyer
- New York Vioxx Lawsuit Lawyer
- New York Xarelto Lawsuit Lawyer
- New York Zostavax Lawsuit Lawyer
- MAIN Defective Drugs & Devices
New York Vioxx Lawsuit Lawyer
Vioxx also referred to as rofecoxib, was sold as a prescription pain reliever and anti-inflammatory medication to treat acute pain, rheumatoid arthritis, osteoarthritis, migraine, and dysmenorrhoea. In 1999 it was approved by the FDA sales to the public began. Five years later it was pulled off the market in response to close to 27,000 lawsuits claiming the drug caused strokes and heart attacks. Even with all the bad news about Vioxx, this was a blockbuster seller that was used by an estimated 20 million Americans.
A full list of Vioxx side effects include:
- Increased risk of heart attacks
- Sudden cardiac arrest
- Abdominal pain
- Upper respiratory infection flu-like symptoms
- High blood pressure
- Sinus infection
- Back pain
- Swelling of lower extremities
- Urinary tract infection
- Ischemic strokes
When you are in pain, you want a safe and effective pain reliever that will not cause strokes, heart attacks or other side effects. Sobo & Sobo, personal injury law leaders understand your anger and frustration and we want to help. Although Vioxx has been taken off the market and is no longer prescribed as a treatment for pain, inflammation, and arthritis, we are horrified that rofecoxib appears set to make a comeback in another form, as treatment for hemophiliacs. We are dedicated to providing legal services to injured victims and want to help those who have suffered after taking Vioxx and to do what we can to prevent rofecoxib from re-entering the marketplace.
Holding Big Pharma Accountable
Vioxx was pulled off the market on September 30, 2004, in response to nearly 27,000 lawsuits claiming this arthritis drug caused strokes and heart attacks. Four years later, the drug’s maker, Kenilworth, New Jersey-based Merck (Merck Group), paid out $4.85 billion to settle those lawsuits all the while insisting it was not at fault. By the time they paid out the settlement monies, Vioxx had been on the market for five years.
Although they claim to not be at fault, it is interesting that a Merck-sponsored Vioxx drug trial discovered there was double the rate of strokes and heart attacks associated with taking the drug. The results of this trial were published in the New England Journal of Medicine and Merck’s comment was they promised to fight every lawsuit brought against it.
Lawsuits were won by the plaintiff in at least five cases, while Merck prevailed in 11 cases. The difficulty in litigation was proving causation in individual cases where plaintiffs may have had pre-existing, co-existing conditions that could be factored into their heart attack or stroke while taking Vioxx.
Merck has been hit with a number of lawsuits over the years. These actions came with hefty price tags. In 2007, Merck paid out $4.85 billion to settle the first round of lawsuits. In 2011, they paid $950 million in response to allegations by the U.S. Department of Justice that it improperly marketed the drug, and in 2012 they settled a class action lawsuit for $220 million.
Bringing Vioxx Back To The Marketplace
A small drug company, Tremeau Pharmaceuticals, located in Cambridge, MA, has indicated it has plans to bring rofecoxib back and market it for severe joint pain caused by hemophilia. The company’s hope is that rofecoxib would be considered by the FDA and other regulators once again because hemophiliacs have far fewer options to manage their acute pain. In the hope of getting rofecoxib back into circulation, Tremeau is calling it TRM-201, being developed specifically for hemophilia patients. The drug’s action has not changed since it was first introduced and then taken off the market. Whether or not Tremeau Pharmaceuticals succeeds in bringing it back for a different class of patients is unknown.
We encourage anyone taking prescription medication to be aware of the drug’s side effects and make certain you keep in close touch with your doctor as soon as you begin to experience them. If you believe that a drug you are taking is causing you additional pain and suffering, you have nothing to lose by taking the time to speak to an experienced defective drug attorney.
Help For Your Defective Drug Case
The attorneys at Sobo & Sobo are personal injury law leaders who have dedicated their careers to helping people. We want to hear your story and help you make informed decisions about how to move forward with your defective drug litigation.
Call Sobo & Sobo at 855-468-7626 as soon as possible for your free initial consultation. Our prompt action, in partnership with you, could make a difference in the outcome of your case. We would be honored to hear your story and look forward to taking the next step toward Winning Together.